Togal

What Togal does

Togal is a German over-the-counter (OTC) pain medication brand, established in 1914 and currently operated as a brand of Kyberg Pharma Vertriebs-GmbH, a private pharmaceutical company headquartered in Oberhaching near Munich that acquired the Togal, flint, and efasit brands from TOGAL-WERK AG in 2019. The company sells two core analgesic products in the German market: Togal Kopfschmerz-Brause + Vitamin C, an effervescent tablet combining acetylsalicylic acid (ASS), vitamin C, and caffeine for accelerated headache relief; and Togal IbuPlus Paracetamol, a film-coated tablet combining ibuprofen 200 mg and paracetamol 500 mg for short-term treatment of mild-to-moderate pain unresponsive to single-substance therapy. Both products are positioned with efficacy claims of faster onset (within 15 minutes for IbuPlus) and longer duration (up to 8 hours) relative to single-active-ingredient comparators, supported by clinical literature on synergistic dual-mechanism analgesia.

Revenue is generated through one-time unit sales of these two OTC products, distributed exclusively via the regulated German pharmacy channel — both physical pharmacies (using PZN codes PZN 03822501 and PZN 19349521) and major online pharmacy platforms including Amazon.de, Shop Apotheke, Medpex, DocMorris, Apotal, and others. Products are not sold direct-to-consumer by Togal. Pricing is set by retail pharmacies and is not publicly disclosed. The brand's go-to-market is anchored in pharmacy-channel recommendations, content marketing through the togal.de Ratgeber (educational pain-condition guides), and an interactive Kopfschmerztest tool for self-classification of headache symptoms. Geographic reach is currently restricted to Germany, although the brand was historically exported to over 30 countries in 1920.

The Togal brand itself is operated with a lean 1–10 employee structure, functioning as one of several legacy brands within Kyberg Group's broader portfolio of private-label, trading, and logistics activities serving the German health market. Kyberg Group is a second-generation family business founded by pharmacist Dr. Herbert Lix in 1969 and now led by brothers Thomas and Stephan Lix, alongside managing directors Marcus Baier and Josef Groß.

Name

Togal

Legal name

Kyberg Pharma Vertriebs-GmbH

Website

https://togal.de

Company type

Private

Founded year

1914

Operating status

Operating

Headcount range

1–10 employees

Short description

Togal is a German OTC pain medication brand, established 1914 and owned by Kyberg Pharma Vertriebs-GmbH since 2019. It sells two combination analgesics — Togal Kopfschmerz-Brause + Vitamin C and Togal IbuPlus Paracetamol (Ibuprofen 200mg / Paracetamol 500mg) — exclusively through German pharmacies and online pharmacy platforms.

Ownership category

akta.pro rank

Product category

Over-the-counter pain relief medications

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Pain Relief & Anti-Inflammatory (Analgesics) (HLAIADAA)

akta.pro secondary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

Keywords

• Pain relief medication
• OTC analgesics
• Headache treatment
• Pharmaceutical products
• Pharmacy medications

Headquarters

HQ city

Oberhaching

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

1. Pharmaceutical Product Sales: Togal generates revenue through the sale of two OTC pain medications: Togal Kopfschmerz-Brause + Vitamin C and Togal IbuPlus Paracetamol. Products are sold through pharmacies and online pharmacy platforms in Germany. Revenue is one-time transaction-based at point of purchase, distributed through pharmacy channel partners.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Togal manufactures and sells over-the-counter (OTC) pain relief medications under a heritage German brand established in 1914. The product portfolio centers on two synergistic analgesic formulations: Togal Kopfschmerz-Brause + Vitamin C (effervescent tablets combining acetylsalicylic acid, vitamin C, and caffeine) and Togal IbuPlus Paracetamol (film-coated tablets combining ibuprofen 200mg and paracetamol 500mg). Products are distributed through the German pharmacy channel and online pharmacy platforms.

Product overview

Togal is a German pharmaceutical brand specializing in over-the-counter pain relief medications, established in 1914 and now part of Kyberg Pharma Vertriebs-GmbH. The company offers two core analgesic products: Togal Kopfschmerz-Brause + Vitamin C (effervescent tablets with acetylsalicylic acid, vitamin C, and caffeine for headaches and mild pain) and Togal IbuPlus Paracetamol (film-coated tablets combining ibuprofen and paracetamol for stronger pain relief when single agents are insufficient). Additionally, Togal provides an interactive Kopfschmerztest (headache test) tool on their website to help users identify headache types. The product portfolio is distributed through pharmacies and online retailers across Germany, with products identifiable by PZN numbers.

Differentiator

Problem solved

Functional benefit

Brands

• Togal Kopfschmerz-Brause + Vitamin C: Pain relief effervescent tablets containing acetylsalicylic acid (ASS), Vitamin C, and caffeine. PZN 03822501. For mild to moderate pain such as headaches.
• Togal IbuPlus Paracetamol

Products and services

• Togal Kopfschmerz-Brause + Vitamin C Effervescent tablets containing Acetylsalicylsäure (ASS) 500 mg, Vitamin C 150 mg, and Coffein 50 mg. Indicated for mild to moderately strong pain such as headaches, fever, and cold-related pain. The combination provides accelerated pain relief through caffeine and stomach-protecting effects from vitamin C.
• Togal IbuPlus Paracetamol 200 mg / 500 mg Filmtabletten Film-coated tablets combining Ibuprofen 200 mg and Paracetamol 500 mg for short-term symptomatic treatment of mild to moderately strong pain that cannot be relieved by either substance alone. Provides faster onset (within 15 minutes) and longer duration (up to 8 hours) compared to single-substance treatments, with good tolerability due to lower ibuprofen dosage.

Quantifiable outcome

• Togal IbuPlus Paracetamol works within 15 minutes (faster than Ibuprofen 400mg alone)
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Kyberg Pharma Vertriebs-GmbHcoreOthers · 1 January 2019Kyberg Pharma acquired the Togal brand along with flint and efasit from TOGAL-WERK AG in 2019. Kyberg Pharma is part of the Kyberg Group, founded in 1969 by pharmacist Dr. Herbert Lix in Munich. Today the company is led by brothers Thomas and Stephan Lix in second-generation leadership. Kyberg Group specializes in private labels, trading activities, and logistics services for the health market.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Kenvue: Global OTC company behind Tylenol/Motrin. Relevant comparable for Togal's OTC analgesic franchise given shared category, regulatory environment (pharmacy distribution), and combination-pain R&D.
• Haleon: Global OTC leader (Voltaren, Advil/Dolormin, ThermaCare). Voltaren and Dolormin compete directly with Togal in the German OTC pain aisle with materially larger marketing investment.
• Bayer (Consumer Health): Global OTC giant whose Aspirin brand is the dominant analgesic in Germany and shapes the category against which Togal directly competes. Aspirin is a direct substitute for Togal's Kopfschmerz-Brause.
• Reckitt Benckiser (Nurofen): Owner of Nurofen, the leading ibuprofen-based OTC brand in Europe. Competes with Togal IbuPlus in the German pharmacy channel through Nurofen's superior brand spend and distribution.
• Sanofi Consumer Health (Thomapyrin): Owner of Thomapyrin, a leading German combination-pain tablet brand and direct substitute for Togal IbuPlus in the same pharmacy channel.

Direct peers

• MCM Klosterfrau: German family-owned OTC and consumer health company with heritage brands in analgesics and cold remedies. Closely mirrors Togal/Kyberg's positioning as a heritage German OTC house competing against multinationals in pharmacies.
• ratiopharm (Teva): One of Germany's largest OTC and generic pharmaceutical brands, directly competing with Togal in the German pharmacy channel across pain, cold/flu and other self-medication categories.
• Stada Arzneimittel: Major German OTC and generics company with a broad portfolio including pain relief brands (e.g., Grippostad, Hedelix). Competes head-to-head with Togal in pharmacies with similar channel and pricing dynamics.
• Dermapharm Holding: German specialty pharma group active in OTC analgesics and consumer health. Closely comparable business model to Togal/Kyberg: narrow product portfolio, pharmacy-channel focused, German-market centric.
• Hexal (Sandoz): Germany's leading generics manufacturer with a strong OTC presence. Its analgesic and combination-pain SKUs directly overlap with Togal's IbuPlus and Kopfschmerz-Brause positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/TogalWerkAG
• LinkedInlinkedin.com/company/togal-werk-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Togal